Global Age-Related Macular Degeneration (AMD) Market By Type (Wet AMD, Dry AMD); By Diagnosis (Visual acuity test, Pupil dilation, Fluorescein angiography, Amsler grid, Indocyanine green angiography, Optical coherence tomography (OCT), Optical coherence tomography angiography (OCTA), Others); By Treatment (Anti-vascular endothelial growth factor (anti-VEGF) drugs – Lucents, Eylea, Avastin, Others, Photodynamic therapy, Photocoagulation, Others); By Stages (Early AMD, Intermediate AMD, Advanced AMD); By Age-Group (Less Than 60, Between 60 to 80, More than 80); By Gender (Male, Female); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030